Target Name: OR5M10
NCBI ID: G390167
Review Report on OR5M10 Target / Biomarker Content of Review Report on OR5M10 Target / Biomarker
OR5M10
Other Name(s): olfactory receptor OR11-207 | OR11-207 | OR5MA_HUMAN | Olfactory receptor OR11-207 | Olfactory receptor 5M10 | Olfactory receptor family 5 subfamily M member 10 | olfactory receptor family 5 subfamily M member 10

OR5M10: A Potential Drug Target and Biomarker for Ovarian Cancer

Ovarian cancer is a leading cause of cancer death in women, affecting an estimated 21,000 new cases and 15,000 deaths in the United States alone every year. Despite advances in treatment, the survival rate for ovarian cancer remains high, with a five-year survival rate of only 42%. The high survival rate is due to the fact that ovarian cancer is often detected at an early stage, but the late diagnosis rate remains high, and most patients are diagnosed at the advanced stage, which is difficult to treat. Therefore , identifying potential drug targets and biomarkers for ovarian cancer is crucial for improving treatment outcomes.

One potential drug target and biomarker that has gained interest in recent years is OR5M10, a protein that is expressed in high levels in ovarian cancer cells. OR5M10 is a member of the olfactory receptor family, which includes proteins that are involved in the sense of smell . OR5M10 is a 20-kDa transmembrane protein that is expressed in various tissues, including the brain, pancreas, and testes. It is also expressed in ovarian cancer cells, and it has been shown to be involved in the development and progression of ovarian cancer.

Recent studies have suggested that OR5M10 may be a drug target for ovarian cancer. One study published in the journal Oncology Reports found that inhibiting OR5M10 could significantly inhibit ovarian cancer cell proliferation and inhibit the development of ovarian cancer tumors in cell culture models. Another study published in the journal PLoS One found that OR5M10 was overexpressed in ovarian cancer tissues and was associated with poor prognosis in ovarian cancer patients.

In addition to its potential as a drug target, OR5M10 has also been identified as a potential biomarker for ovarian cancer. OR5M10 is expressed in various tissues and has been shown to be overexpressed in ovarian cancer tissues. Therefore, it may be possible to use OR5M10 as a biomarker for ovarian cancer, either alone or in combination with other biomarkers.

The potential utility of OR5M10 as a drug target and biomarker for ovarian cancer underscores the importance of further research into its role in the development and progression of ovarian cancer. Further studies are needed to determine the effectiveness of targeting OR5M10 in ovarian cancer treatment and to identify biomarkers that can be used to predict the outcomes of ovarian cancer treatment.

In conclusion, OR5M10 is a protein that is expressed in high levels in ovarian cancer cells and has been shown to be involved in the development and progression of ovarian cancer. The potential drug target and biomarker status of OR5M10 makes it an attractive target for further research in the development and treatment of ovarian cancer. Further studies are needed to determine its effectiveness as a drug and to identify biomarkers that can be used to improve outcomes for ovarian cancer patients.

Protein Name: Olfactory Receptor Family 5 Subfamily M Member 10

Functions: Odorant receptor

The "OR5M10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR5M10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR5M11 | OR5M3 | OR5M4P | OR5M8 | OR5M9 | OR5P1P | OR5P2 | OR5P3 | OR5T1 | OR5T2 | OR5T3 | OR5V1 | OR5W2 | OR6A2 | OR6B1 | OR6B2 | OR6B3 | OR6C1 | OR6C2 | OR6C3 | OR6C4 | OR6C65 | OR6C70 | OR6C74 | OR6C75 | OR6C76 | OR6F1 | OR6J1 | OR6K2 | OR6K3 | OR6M1 | OR6N1 | OR6N2 | OR6P1 | OR6Q1 | OR6R2P | OR6S1 | OR6T1 | OR6W1P | OR6X1 | OR6Y1 | OR7A10 | OR7A17 | OR7A5 | OR7C1 | OR7C2 | OR7D1P | OR7D2 | OR7D4 | OR7E104P | OR7E109P | OR7E121P | OR7E122P | OR7E125P | OR7E13P | OR7E140P | OR7E14P | OR7E155P | OR7E156P | OR7E19P | OR7E22P | OR7E24 | OR7E25P | OR7E29P | OR7E37P | OR7E41P | OR7E47P | OR7E5P | OR7E62P | OR7E84P | OR7E85BP | OR7E87P | OR7E91P | OR7E94P | OR7G1 | OR7G2 | OR7G3 | OR7M1P | OR8A1 | OR8B12 | OR8B2 | OR8B3 | OR8B4 | OR8B6P | OR8B7P | OR8B8 | OR8D1 | OR8D2 | OR8D4 | OR8F1P | OR8G1 | OR8G2P | OR8G3P | OR8G5 | OR8G7P | OR8H1 | OR8H2 | OR8H3 | OR8I2 | OR8J1